Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial

著者: Kang Wang, Yan‐Jun Xiang, Hongming Yu, Yuqiang Cheng, Zong‐Han Liu, Yingyi Qin, Jie Shi, Wei‐Xing Guo, Chong‐De Lu, Yaxin Zheng, Feiguo Zhou, Mao-Lin Yan, Hongkun Zhou, Chao Liang, Fan Zhang, Wenjing Wei, Wan Yee Lau, Jing‐Jing Li, Yanfang Liu, Shuqun Cheng - Nature Medicine 2024 被引用: 120